Ves-CP-M [[IL,L13Y], TempY

General Information


DRACP ID  DRACP04050

Peptide Name   Ves-CP-M [[IL,L13Y], TempY

Sequence  FLPLIGKLLSGLY

Sequence Length  13

UniProt ID  P17232 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C72H116N14O16

Absent amino acids  ACDEHMNQRTVW

Common amino acids  L

Mass  164803

Pl  9.3

Basic residues  1

Acidic residues  0

Hydrophobic residues  7

Net charge  1

Boman Index  2529

Hydrophobicity  137.69

Aliphatic Index  180

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  1490

Absorbance 280nm  124.17

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Two Novel Anticancer Peptides from Aurein 12

Doi Not available

Year  2011

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  16499

DRACP is developed by Dr.Zheng's team.